An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.
Manufactured by
NOROVA
China
NOROVA specializes in personalized precision medicine for malignant tumors, serving as a biomedical innovation and life sciences R&D center in the Beijing-Tianjin region. The company operates a proprietary tumor organoid precision diagnosis platform integrating drug sensitivity testing, high-throughput drug screening, and genetic testing. NOROVA also develops tumor microenvironment organ-on-chip and multi-organ chip technologies for drug development applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 4 relevant products
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
GeneCker Co., Ltd.
South Korea · 5 relevant products
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 83 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
GeneCker Co., Ltd. · South Korea
Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.
80 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products